Pentoxifylline治療腎小管間質纖維化
Date Issued
2005
Date
2005
Author(s)
林水龍
DOI
932314B002144
Abstract
Pentoxifylline (PTX) is a potent inhibitor of connective tissue growth factor (CTGF), but its
underlying mechanism is poorly understood. Here, we demonstrated that PTX inhibited not only
transforming growth factor-β 1 (TGF- β 1)-induced CTGF expression, but also CTGF-induced
collagen I (1) [Col I (1)] expression in NRK-49F and α -smooth muscle actin expression in
NRK-52E cells. The mechanism by which PTX reduced CTGF in NRK-49F and NRK-52E was
investigated. Activation of Smad3/4 was essential for TGF-β 1-induced CTGF transcription, but
PTX did not interfere with TGF-β 1 signaling to Smad2/3 activation, association with Smad4, and
their nuclear translocation. However, PTX was capable of blocking activation of TGF-β 1-induced
Smad3/4-dependent reporter as well as CTGF promoter, suggesting that PTX affects a factor that
acts cooperatively with Smad3/4 to execute transcriptional activation. We found that PTX increased
intracellular cyclic adenine monophosphate (cAMP) and caused cAMP response element binding
protein phosphorylated. The protein kinase A (PKA) antagonist H89 abolished the inhibitory effect
of PTX on Smad3/4-dependent CTGF transcription, whereas dibutyryl cAMP and forskolin
recapitulated the inhibitory effect. In conclusion, our results indicate that PTX inhibits CTGF
expression by interfering with Smad3/4-dependent CTGF transcription through PKA and blocks the
profibrogenic effects of CTGF on renal cells.
Subjects
connective tissue growth factor
epithelial-mesenchymal
transdifferentiation
transdifferentiation
transforming growth factor-β1
Publisher
臺北市：國立臺灣大學醫學院內科
Type
report
File(s)![Thumbnail Image]()
Loading...
Name
932314B002144.pdf
Size
3.57 MB
Format
Adobe PDF
Checksum
(MD5):0cb01e726d3c32eda7177cf525fc508d